Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review - Quiz - MDSpire

Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review

  • By

  • Michiel A van Nieuwenhoven

  • July 13, 2026

Share

Original Source(s)

Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review

  • by Michiel A van Nieuwenhoven

  • July 13, 2026

Related Content

Commentary: SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo

The role of Astragalus membranaceus and its derivatives in digestive system diseases: reconstruction of immune tolerance

Evidence-based summary of optimal home self-management for elderly ostomy patients